June 24, 2008

Press Release no. 01

NSE completes its 2089^th Normal Settlement

The Exchange has successfully completed its 2089^th Normal Settlement (Rolling T+2 following SEBI directive) since inception i.e., Settlement Number N – 2008117 on June 24, 2008. The settlement statistics is as follows:

Particulars	Values
	N – 2008117
Total traded quantity (lakhs)	4816.12
Total traded value (Rs. In Crores)	12009.49
Total value of the settlement (Securities) (Rs. In Crores)	2626.45
Total value of the settlement (Funds) (Rs. In Crores)	1059.52
Shortages for the settlement	0.20%
% of Delivery ( No. of shares deliverable / No. of shares traded )	21.93%

Retail Debt Market have completed its 1363^rd settlements details of which is as follows:

Settlement No.	Traded Value	Settlement Value
		Securities	Funds
D- 2008117	NIL	NIL	NIL

Press Release no. 02

News about Sun Pharmaceuticals Industries Limited

The media had reports that Sun Pharmaceuticals Industries Ltd may acquire a substantial stake in Torrent Pharmaceuticals.

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.

Sun Pharmaceuticals Industries Ltd has vide its letter inter-alia stated, “We are not looking for any domestic acquisitions and we do not comment on any market rumours."

Press Release no. 03

News about Torrent Pharmaceuticals Limited

The media had reports that Sun Pharmaceuticals may acquire a substantial stake in Torrent Pharmaceuticals Ltd.

The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company.

Torrent Pharmaceuticals Ltd. has vide its letter inter-alia stated, "Company denies that it or its promoters' intend to sell any stake to Sun Pharmaceuticals Ltd."